MedTrace Logo

Management of Patients With Keratoconus With Intacs

NCT00384501 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2006-10-06

No results posted yet for this study

Summary

Purpose To evaluate long-term follow up of Intacs microthin prescription inserts (Addition Technology Inc, Fremont, Calif) for the management of keratoconus.

Design A long-term (five years) retrospective, follow-up study

Conditions

  • Keratoconus

Interventions

DEVICE

Intacs

Sponsors & Collaborators

  • University Hospital of Crete

    lead OTHER

Principal Investigators

  • George D Kymionis, M.D., Ph.D · University of Crete

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-01-31
Completion
2006-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00384501 on ClinicalTrials.gov